Mahdi Mahdi

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

Sanjay Ramakrishnan, Dan V. Nicolau, Beverly Langford et al. · The Lancet Respiratory Medicine · 2021 · 427 citations · Full text

Early Covid-19, Respiratory Diseases, Respiratory Infection +6

Clinical trials and progress with paclitaxel in ovarian cancer

Sanjeev Kumar, Mahdi Mahdi, Shah et al. · International Journal of Women s Health · 2010 · 100 citations · Full text

Medicine, Pharmacology, Pathology +9

Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial

Sanjay Ramakrishnan, Richard Russell, Hafiz Taha Mahmood et al. · The Lancet Respiratory Medicine · 2024 · 81 citations · Full text

Asthma, Inflammatory Lung Disease, Lung Inflammation +8

Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial

Sanjay Ramakrishnan, Helen Jeffers, B Langford-Wiley et al. · The Lancet Respiratory Medicine · 2023 · 64 citations · Full text

Livelihood Change and Livelihood Sustainability in the Uplands of Lembang Subwatershed, West Sumatra, Indonesia, in a Changing Natural Resource Management Context

Mahdi Mahdi, Ganesh P. Shivakoti, Dietrich Schmidt‐Vogt · Environmental Management · 2008 · 60 citations

Engineering, Livelihood Security, Natural Resource +13